A Multi-centre Randomised Double Blind Placebo Controlled Study Comparing Two Regimens of Combination Therapy in Early DMARD Naive Rheumatoid Arthritis.

Trial Profile

A Multi-centre Randomised Double Blind Placebo Controlled Study Comparing Two Regimens of Combination Therapy in Early DMARD Naive Rheumatoid Arthritis.

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Sep 2016

At a glance

  • Drugs Infliximab (Primary) ; Methotrexate; Methylprednisolone; Methylprednisolone
  • Indications Rheumatoid arthritis
  • Focus Biomarker; Pharmacodynamics; Therapeutic Use
  • Acronyms IDEA
  • Most Recent Events

    • 16 Sep 2016 Results of a cardiovascular substudy (n=79) published in the Rheumatology
    • 29 Oct 2013 Results of the cardiovascular analysis (n=79) presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.
    • 09 Jun 2012 Results assessing changes in levels of cardiovascular biomarkers presented at the 13th Annual Congress of the European League Against Rheumatism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top